Ken Griffin Cardiol Therapeutics Inc. Put Options Transaction History

Citadel Advisors LLC

  • $505 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$1.83 - $2.48 $3,843 - $5,208
2,100 Added 28.38%
9,500 $18,000
Q2 2024

Aug 14, 2024
BUY
$1.67 - $2.97 $12,358 - $21,978
7,400 New
7,400 $14,000
Q4 2023

Feb 14, 2024
BUY
$0.67 - $1.0 $670 - $1,000
1,000 New
1,000 $0
Q4 2022

Feb 14, 2023
BUY
$0.48 - $1.0 $768 - $1,600
1,600 New
1,600 $0

Others Institutions Holding CRDL

# of Institutions
45
Shares Held
5.07M
Call Options Held
5.2K
Put Options Held
9.5K
View Full List

About Cardiol Therapeutics Inc.

CRDL Quotes by TradingView
  • Ticker CRDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 61,942,500
  • Market Cap $98.5M
  • Description
  • Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...
More about CRDL
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email